amr
-
An expert's opinion: Interview with Dr Pablo Moral on the fight against antimicrobial resistance
Dr Pablo Moral is a bioscientist working at GSK Global Health Medicines. As the industrial lead of the EU-funded END2AMR project, a European consortium launched in 2026 to pioneer novel therapies against drug-resistant pathogens, Dr. Moral stands at the forefront of the fight against antimicrobial resistance,... -
An expert's opinion: Interview with Prof. Christian Giske on the fight against antimicrobial resistance
Professor Christian Giske is a Norwegian microbiologist, Professor of Clinical Bacteriology at the Karolinska Institutet in Sweden, and Head of Antimicrobial Resistance and Healthcare-Associated Infections at the European Centre for Disease Prevention and Control (ECDC). He has spent his career mapping... -
European Antibiotic Awareness Day turns 18: What have we learnt so far?
Since the discovery of bacterial infections in the first half of the 20th century, humanity has relied on the great healing capabilities of antibiotics as a cornerstone of modern medicine - perhaps too heavily. Excessive antibiotic consumption has accelerated antimicrobial resistance (AMR) in bacteria,... -
Phage therapy: From last resort to routine medicine
Ever more often, bacteria, viruses, fungi and parasites stop responding to the medicines designed to treat them, such as antibiotics. This antimicrobial resistance (AMR) poses a growing threat, with an estimated 8.22 million deaths globally in 2050. Armed conflicts are escalating the situation: conflicts... -
STOA’s work on health during a term marked by the Covid-19 pandemic
In the 2019-2024 European Parliament legislative term, the EU faced the biggest health crisis of a generation: Covid-19 and its consequences. The pandemic put health in the spotlight of European decision-making and it also featured prominently in the work of the European Parliament’s panel for the...